Anhedonia in schizophrenia

Current Psychiatry Reports

Volumn 8, Issue 4, 2006, Pages 322-328

  Wolf, Daniel H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ARIPIPRAZOLE; DOPAMINE; GLUTAMIC ACID; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE; SEROTONIN;

ANHEDONIA; APATHY; BEHAVIOR THERAPY; BLUNTED AFFECT; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; DEPRESSION; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; DOPAMINERGIC SYSTEM; DRUG MECHANISM; DRUG RESPONSE; DYSPHORIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; NEGATIVE SYNDROME; PATIENT COMPLIANCE; PESSIMISM; PET THERAPY; PHENOTYPE; POSITIVE SYNDROME; PREVALENCE; PSYCHOSOCIAL CARE; RATING SCALE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SIDE EFFECT; SINGLE DRUG DOSE; SOCIAL INTERACTION; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; DOPAMINE ANTAGONISTS; HUMANS; MOOD DISORDERS; RECEPTORS, DOPAMINE D2; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 33747172828     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-006-0069-0     Document Type: Review

References (50)

1. Harvey PD, Koren D, Reichenberg A, et al.: Negative symptoms and cognitive deficits: What is the nature of their relationship? Schizophr Bull 2006, 32:250-258.
2. Ribot TH: The Psychology of Emotions. London: Scott; 1897.
3. Kraepelin E: Dementia Praecox and Paraphrenia. Translated by Barclay RM. Huntington, NY: Krieger; 1971 (1919).
4. Bleuler E: Dementia Praecox or the Group of Schizophrenias. Translated by Zinkin J. New York: International Universities Press; 1950 (1911).
5. Meehl PE: Schizotaxia, schizotypy, schizophrenia. Am Psychol 1962, 17:827-838.
6. Horan WP, Kring AM, Blanchard JJ: Anhedonia in schizophrenia: a review of assessment strategies. Schizophr Bull 2006, 32:259-273.
7. Schurhoff F, Szoke A, Bellivier F, et al.: Anhedonia in schizophrenia: a distinct familial subtype? Schizophr Res 2003, 61:59-66.
8. Suslow T, Roestel C, Ohrmann P, et al.: The experience of basic emotions in schizophrenia with and without affective negative symptoms. Compr Psychiatry 2003, 44:303-310.
9. Gooding DC, Tallent KA, Matts CW: Clinical status of at-risk individuals 5 years later: further validation of the psychometric high-risk strategy. J Abnorm Psychol 2005, 114:170-175.
10. Katsanis J, Iacono WG, Beiser M: Anhedonia and perceptual aberration in first-episode psychotic patients and their relatives. J Abnorm Psychol 1990, 99:202-206.
11. Rey ER, Bailer J, Brauer W, et al.: Stability trends and longitudinal correlations of negative and positive syndromes within a three-year follow-up of initially hospitalized schizophrenics. Acta Psychiatr Scand 1994, 90:405-412.
12. Herbener ES, Harrow M: The course of anhedonia during 10 years of schizophrenic illness. J Abnorm Psychol 2002, 111:237-248.
13. Herbener ES, Harrow M, Hill SK: Change in the relationship between anhedonia and functional deficits over a 20-year period in individuals with schizophrenia. Schizophr Res 2005, 75:97-105.
14. Milev P, Ho BC, Arndt S, et al.: Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am J Psychiatry 2005, 162:495-506.
15. Kirkpatrick B, Fenton WS, Carpenter WT, Jr, et al.: The NIMH-MATRICS consensus statement on negative symptoms. Schizophr Bull 2006, 32:214-219.
16. Blanchard JJ, Cohen AS: The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr Bull 2006, 32:238-245.
17. Andreasen NC: Negative symptoms in schizophrenia. Definition and reliability. Arch Gen Psychiatry 1982, 39:784-788.
18. Cohen AS, Dinzeo TJ, Nienow TM, et al.: Diminished emotionality and social functioning in schizophrenia. J Nerv Ment Dis 2005, 193:796-802.
19. Horan WP, Green MF, Kring AM, et al.: Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? J Abnorm Psychol 2006, In press.
20. Rector NA, Beck AT, Stolar N: The negative symptoms of schizophrenia: a cognitive perspective. Can J Psychiatry 2005, 50:247-257.
21. Gard DE, Germans Gard M, Kring AM, et al.: Anticipatory and consummatory components of the experience of pleasure: a scale development study. J Res Pers 2006, In press.
22. Gard DE, Kring AM, Germans MK, et al.: Emotion in the daily life of patients with schizophrenia. Poster presented at Annual Meeting of the Society for Research in Psychopathology. Boulder, CO; November 30-December 3, 2000.
23. Myin-Germeys I, Delespaul PA, deVries MW: Schizophrenia patients are more emotionally active than is assumed based on their behavior. Schizophr Bull 2000, 26:847-854.
24. Aghevli MA, Blanchard JJ, Horan WP: The expression and experience of emotion in schizophrenia: a study of social interactions. Psychiatry Res 2003, 119:261-270.
25. Kring AM, Neale JM: Do schizophrenic patients show a disjunctive relationship among expressive, experiential, and psychophysiological components of emotion? J Abnorm Psychol 1996, 105:249-257.
26. Hempel RJ, Tulen JH, van Beveren NJ, et al.: Physiological responsivity to emotional pictures in schizophrenia. J Psychiatr Res 2005, 39:509-518.
27. Plailly J, d'Amato T, Saoud M, Royet JP: Left temporo-limbic and orbital dysfunction in schizophrenia during odor familiarity and hedonicity judgments. Neuroimage 2006, 29:302-313.
28. Taylor SF, Phan KL, Britton JC, et al.: Neural response to emotional salience in schizophrenia. Neuropsychopharmacology 2005, 30:984-995.
29. Kirkpatrick B, Buchanan RW, Ross DE, et al.: A separate disease within the syndrome of schizophrenia. Arch Gen Psychiatry 2001, 58:165-171.
30. Gur RE, Kohler CG, Ragland JD, et al.: Flat affect in schizophrenia: relation to emotion processing and neurocognitive measures. Schizophr Bull 2006, 32:279-287.
31. Iancu I, Poreh A, Lehman B, et al.: The Positive and Negative Symptoms Questionnaire: a self-report scale in schizophrenia. Compr Psychiatry 2005, 46:61-66.
32. Berridge KC, Robinson TE: Parsing reward. Trends Neurosci 2003, 26:507-513.
33. an der Heiden W, Konnecke R, Maurer K, et al.: Depression in the long-term course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2005, 255:174-184.
34. Kontaxakis VP, Kollias CT, Havaki-Kontaxaki BJ, et al.: Physical anhedonia in the acute phase of schizophrenia. Ann Gen Psychiatry 2006, 5:1.
35. Barch DM: The relationships among cognition, motivation, and emotion in schizophrenia: how much and how little we know. Schizophr Bull 2005, 31:875-881.
36. Wittmann BC, Schott BH, Guderian S, et al.: Reward-related FMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation. Neuron 2005, 45:459-467.
37. Kayton L, Koh SD: Hypohedonia in schizophrenia. J Nerv Ment Dis 1975, 161:412-420.
38. Brebion G, David AS, Jones H, et al.: Hallucinations, negative symptoms, and response bias in a verbal recognition task in schizophrenia. Neuropsychology 2005, 19:612-617.
39. Awad AG, Voruganti LN: Neuroleptic dysphoria: revisiting the concept 50 years later. Acta Psychiatr Scand Suppl 2005, 111(Suppl 427):6-13.
40. Artaloytia JF, Arango C, Lahti A, et al.: Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. Am J Psychiatry 2006, 163:488-493.
41. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
42. Smith AJ, Becker S, Kapur S: A computational model of the functional role of the ventral-striatal D2 receptor in the expression of previously acquired behaviors. Neural Comput 2005, 17:361-395.
43. Abi-Dargham A: Do we still believe in the dopamine hypothesis? New data bring new evidence. Int J Neuropsychopharmacol 2004, 7(Suppl 1):S1-S5.
44. Juckel G, Schlagenhauf F, Koslowski M, et al.: Dysfunction of ventral striatal reward prediction in schizophrenia. Neuroimage 2006, 29:409-416.
45. Laruelle M: The role of endogenous sensitization in the pathophysiology of schizophrenia: implications from recent brain imaging studies. Brain Res Brain Res Rev 2000, 31:371-384.
46. Kalivas PW, Volkow ND: The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005, 162:1403-1413.
47. van Nimwegen L, de Haan L, van Beveren N, et al.: Adolescence, schizophrenia and drug abuse: a window of vulnerability. Acta Psychiatr Scand Suppl 2005, 111(Suppl 427):35-42.
48. Erhart SM, Marder SR, Carpenter WT: Treatment of schizophrenia negative symptoms: future prospects. Schizophr Bull 2006, 32:234-237.
49. Nathans-Barel I, Feldman P, Berger B, et al.: Animal-assisted therapy ameliorates anhedonia in schizophrenia patients. A controlled pilot study. Psychother Psychosom 2005, 74:31-35.
50. Bryson G, Lysaker P, Bell M: Quality of life benefits of paid work activity in schizophrenia. Schizophr Bull 2002, 28:249-257.